<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04934761</url>
  </required_header>
  <id_info>
    <org_study_id>202103000022</org_study_id>
    <nct_id>NCT04934761</nct_id>
  </id_info>
  <brief_title>Study on the Effect of Capacity Shock Intervention Under Goal-directed Hemodynamic Management on P-V Loop</brief_title>
  <official_title>Study on the Effect of Capacity Shock Intervention Under Goal-directed Hemodynamic Management on P-V Loop-based Myocardial Contraction and Work</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangzhou Red Cross Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangzhou Red Cross Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      By observing the changes of P-V loop in capacity shock intervention Under Goal-directed&#xD;
      Hemodynamic Management in patients undergoing total knee replacement, we investigate the&#xD;
      effect of capacity shock on cardiac contractility and work in order to seek a more effective&#xD;
      target plan of capacity shock for intraoperative patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective:By observing the changes of P-V loop in capacity shock intervention Under&#xD;
      Goal-directed Hemodynamic Management in patients undergoing total knee replacement, we&#xD;
      investigate the effect of capacity shock on cardiac contractility and work in order to seek a&#xD;
      more effective target plan of capacity shock for intraoperative patients.&#xD;
&#xD;
      Methods:20 patients with total knee replacement were enrolled in this study. Capacity shock&#xD;
      therapy was used in Group A(n=10) and conventional strategy was used in Group B (n=10). V(t)&#xD;
      was measured and calculated using TEE and P(t) was acquired by the analysis of&#xD;
      patients'radial artery pressure waveform. We set five time points of parameter acquisition:&#xD;
      after grouping (T1), the first shock completion(T2), the second shock completion (T3), 1h&#xD;
      after shock treatment (T4), and operation completion(T5). We make up the P-V loop fitting&#xD;
      P(t) and V(t) at each time point after the calibration of cardiac cycle.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Actual">June 10, 2021</completion_date>
  <primary_completion_date type="Actual">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ees</measure>
    <time_frame>Baseline，After induction</time_frame>
    <description>Ees（End-systole Elasticity，mmHg/ml）</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ees</measure>
    <time_frame>Immediately after the intervention,complete of the first round of the fluid challenge</time_frame>
    <description>Ees（End-systole Elasticity，mmHg/ml）</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ees</measure>
    <time_frame>Immediately after the intervention,complete of the second round of the fluid challenge</time_frame>
    <description>Arterial elasticity is an invasively determined parameter of arterial load that is inversely related to arterial compliance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ees</measure>
    <time_frame>1h after the first fluid challenge</time_frame>
    <description>Ees（End-systole Elasticity，mmHg/ml）</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ees</measure>
    <time_frame>At the end of surgery</time_frame>
    <description>Ees（End-systole Elasticity，mmHg/ml）</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SW</measure>
    <time_frame>Baseline，after induction</time_frame>
    <description>SW（Stroke Volume，mmHg·ml）</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SW</measure>
    <time_frame>Immediately after the intervention,complete of the first round of the fluid challenge</time_frame>
    <description>SW（Stroke Volume，mmHg·ml）</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SW</measure>
    <time_frame>Immediately after the intervention,complete of the second round of the fluid challenge</time_frame>
    <description>SW（Stroke Volume，mmHg·ml）</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SW</measure>
    <time_frame>1h after the first fluid challenge</time_frame>
    <description>SW（Stroke Volume，mmHg·ml）</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SW</measure>
    <time_frame>At the end of surgery</time_frame>
    <description>SW（Stroke Volume，mmHg·ml）</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ea</measure>
    <time_frame>Baseline，after induction</time_frame>
    <description>Ea(Arterial elasticity, mmHg·ml)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ea</measure>
    <time_frame>Immediately after the intervention,complete of the first round of the fluid challenge</time_frame>
    <description>Ea(Arterial elasticity, mmHg·ml)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ea</measure>
    <time_frame>Immediately after the intervention,complete of the second round of the fluid challenge</time_frame>
    <description>Ea(Arterial elasticity, mmHg·ml)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ea</measure>
    <time_frame>1h after the first fluid challenge</time_frame>
    <description>Ea(Arterial elasticity, mmHg·ml)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ea</measure>
    <time_frame>At the end of surgery</time_frame>
    <description>Ea(Arterial elasticity, mmHg·ml)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Hemodynamics</condition>
  <arm_group>
    <arm_group_label>capacity shock</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2ml/kg succinylateol gelatin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>routine management</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>conventional strategy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fluid challenge strategy</intervention_name>
    <description>Patients received 2ml/kg of succinylateol gelatin within 10 min for fluid shock therapy after grouping, taking SVV as the management target. If SVV&lt; 13% after shock therapy, the shock therapy was stopped and the infusion was maintained with 4ml/kg/h of crystal solution. If SVV ≥ 13% and ΔSV &lt;10%, the individual would be excluded from the experiment. If SVV ≥ 13% but ΔSV≥10%, 2ml/kg of succinylateol gelatin was given again within 10 min for liquid shock therapy until SVV&lt;13%, and 4ml/kg/h of crystal solution was maintained after reaching the target. If SVV≥ 13% after two shock treatments, they were excluded from the experiment. We excluded patients whose intraoperative bleeding ≥400ml and operative time ≥5 hours from the group.</description>
    <arm_group_label>capacity shock</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional strategy</intervention_name>
    <description>4ml/kg/h of crystal solution was maintained. We excluded patients whose intraoperative bleeding ≥400ml and operative time ≥5 hours from the group.</description>
    <arm_group_label>routine management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        ASAI-II age 40- 70 weight 48 - 72 kg.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Body mass index &gt;30 or &lt;15 kg/m2 Valve heart disease Left ventricular ejection fraction&#xD;
        (LVEF) is less than 50% History of lung disease Preoperative arrhythmic disorder Permanent&#xD;
        pacemaker Need for mechanical heart Support, Severe extrinsic vascular disease Valve&#xD;
        dysfunction OED monitoring probe insertion contraindications Patients with preoperative&#xD;
        assessments&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cao Yang</last_name>
    <role>Study Director</role>
    <affiliation>Guangzhou Red Cross Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Guangzhou Red cross hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510220</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 25, 2021</study_first_submitted>
  <study_first_submitted_qc>June 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2021</study_first_posted>
  <last_update_submitted>June 19, 2021</last_update_submitted>
  <last_update_submitted_qc>June 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guangzhou Red Cross Hospital</investigator_affiliation>
    <investigator_full_name>Liang Bing</investigator_full_name>
    <investigator_title>Deputy Director of Anesthesiology Physicians</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

